AccordQuick system efficient nucleic acid extraction and PCR amplification from sample to result
Publish Time: 2025-04-15
In the current field of medical technology, rapid and accurate nucleic acid testing is of vital importance for disease diagnosis, epidemic prevention and control, and genetic disease screening. However, the traditional nucleic acid testing process often involves multiple cumbersome manual operation steps, which is not only time-consuming and labor-intensive, but also prone to errors. In order to solve this problem, the AccordQuick series of fully automatic thin-film microfluidic nucleic acid detection all-in-one machines came into being. With its unique thin-film microfluidic technology and fluorescent quantitative PCR technology, it has achieved efficient nucleic acid extraction and PCR amplification from sample to result, bringing a new revolution to the medical industry.
One-stop efficient solution
The biggest feature of the AccordQuick system is that it completes nucleic acid extraction, PCR amplification and result analysis in one stop. This innovative design greatly simplifies the nucleic acid testing process, integrating the testing process that originally required multiple devices and multiple steps to complete into a compact and efficient system. Whether it is for hospital laboratories, CDCs or primary medical institutions, the AccordQuick system can provide convenient and fast nucleic acid testing services.
Unique advantages of thin-film microfluidics
The thin-film microfluidics technology used by the AccordQuick system is the key to its high-efficiency performance. This technology achieves precise control and efficient processing of trace samples through micron-level channels and structures. During the nucleic acid extraction process, thin-film microfluidics can ensure the full lysis of samples and the efficient purification of nucleic acids, while avoiding the cross-contamination problems that may occur in traditional methods. In addition, thin-film microfluidics also enables the system to have higher throughput and faster processing speed, and can process multiple samples at the same time to meet the needs of high-throughput detection.
Accurate detection of fluorescent quantitative PCR technology
In the PCR amplification stage, the AccordQuick system uses fluorescent quantitative PCR technology. This technology can accurately determine the amplification of the target nucleic acid by real-time monitoring of the changes in the fluorescent signal during the PCR reaction, thereby achieving accurate detection of pathogens. Fluorescent quantitative PCR technology not only has extremely high sensitivity and specificity, but also can simultaneously detect multiple pathogens and gene targets, greatly improving the efficiency and accuracy of detection.
Easy to operate and wide range of applications
The operating interface of the AccordQuick system is simple and clear. Users only need to follow the prompts to complete the entire detection process. Both professional technicians and non-professionals can easily get started. In addition, the AccordQuick system has a wide range of applications and can be used for the detection of various sample types, including blood, saliva, urine, etc. This makes it play an important role in many fields such as clinical diagnosis, epidemic prevention and control, and food safety testing.
High sensitivity and specificity to ensure detection accuracy
In nucleic acid detection, sensitivity and specificity are important indicators for measuring detection performance. The AccordQuick system achieves high-sensitivity detection of target nucleic acids with its unique thin-film microfluidics technology and fluorescent quantitative PCR technology. Even if the target nucleic acid content in the sample is extremely low, the system can accurately detect it. At the same time, the system also has high specificity, which can effectively avoid nonspecific amplification and false positive results, thereby ensuring the accuracy of the detection.
The emergence of the AccordQuick series of fully automatic thin-film microfluidics nucleic acid detection all-in-one machines has brought a new nucleic acid detection solution to the medical industry. It has become a leader in the current nucleic acid testing field by virtue of its one-stop efficient solution, unique advantages of thin film microfluidic technology, precise detection of fluorescent quantitative PCR technology, simple operation, high sensitivity and specificity.
